## SCHW: The Charles Schwab Corporation - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 0.2% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($96.63)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Schwab stock slips as Fed minutes put rate outlook back in focus**
- Source: ts2.tech | 20251230T140000 | Somewhat-Bearish | Relevance: 100%
- Charles Schwab Corp's shares fell by 0.6% to $100.69 after opening, with the stock being particularly sensitive to interest-rate expectations given its revenue generation from client cash. Investors are closely watching Federal Reserve minutes for clues on future policy paths, especially regarding potential rate cuts in 2026, which could impact Schwab's net interest income. Additionally, insider transactions show a managing director exercised options and sold shares, while upcoming Q4 results and a Winter Business Update will focus on net new assets and client cash trends.

**2. Charles Schwab (NYSE:SCHW) Insider Jonathan Beatty Sells 2,000 Shares**
- Source: MarketBeat | 20251230T002152 | Neutral | Relevance: 100%
- Jonathan Beatty, an insider at Charles Schwab (NYSE:SCHW), sold 2,000 shares of the company's stock for a total of $204,020. This transaction reduced his holding by 14.36% to 11,923 shares. The company recently reported strong earnings with $1.31 EPS and 26.6% year-over-year revenue growth, and analysts have a "Moderate Buy" rating with a consensus target price of $108.84.

**3. Schwab Shares Keep Seeing Rare Bullish Inflow Signals**
- Source: FXEmpire | 20251231T174306 | Bullish | Relevance: 100%
- Charles Schwab Corp. (SCHW) has shown significant growth, with shares up 36% this year and a 1,174% increase since 1998, driven by strong institutional support and robust financial performance. The company reported record revenue and net income in Q3 fiscal 2025, attracting "Big Money" investors. Its consistent financial strength and unusual buy pressure suggest it could be a valuable addition to a diversified portfolio.

**4. Ascent Group LLC Boosts Holdings in The Charles Schwab Corporation $SCHW**
- Source: MarketBeat | 20251231T084733 | Bullish | Relevance: 100%
- Ascent Group LLC increased its stake in The Charles Schwab Corporation (NYSE:SCHW) by 15.2% during the third quarter, bringing its total holdings to 118,013 shares valued at $11.27 million. Other institutional investors also adjusted their positions in SCHW, with the stock currently having an average "Moderate Buy" rating and a target price of $108.84 from analysts. Charles Schwab recently announced a quarterly dividend of $0.27 per share, paid on November 28th.

**5. Charles Schwab Corp. stock: quiet rebound, cautious optimism and a market still scarred by last year**
- Source: AD HOC NEWS | 20251230T130835 | Somewhat-Bullish | Relevance: 100%
- Charles Schwab Corp. stock has shown a modest rebound and a solid multi-month recovery, yet it still trades significantly below its 52-week peak after last year's banking shock. Wall Street analysts show cautious optimism, with most rating the stock as Buy or Overweight, based on the resilience of Schwab's business model and its ability to navigate interest rate fluctuations and integrate TD Ameritrade. The future performance hinges on the interest rate environment, successful TD Ameritrade integration, and continuous investment in competitive digital wealth services.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $148 | $139 | +6% |
| 2025-12-12 | Barclays | $111 | $115 | -3% |
| 2025-12-10 | B of A Securiti | $91 | $88 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Overweight |
| 2025-12-12 | Barclays | main | Overweight |
| 2025-12-10 | B of A Securiti | main | Underperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.06M) |
| Sells | 14 ($13.64M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 8.5% (+0.3%)
- Blackrock Inc.: 7.4% (+3.2%)
- JPMORGAN CHASE & CO: 6.8% (+71.6%)
- Dodge & Cox Inc.: 4.7% (-1.6%)
- State Street Corpora: 4.1% (+0.9%)

### Key Risks

1. Heavy insider selling: $14M sold (14 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.70 indicates undervaluation relative to growth. Quality metrics strong (margin 36%). Insider selling cluster ($13.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $181.4B |
| Beta | 0.96 |
| 52W Range | $65.88 - $102.28 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.70 |
| Forward P/E | 17.8 |
| Current P/E | 20.8 |
| YoY Growth | 17.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.1% to 0.2% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.8pp (needs >3.0% for momentum thesis). MRS_5 (-0.2%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -F0L (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.25% (CS: 70) | Neutral |
| RSI_14 | 61.6 | Neutral |
| MACD Histogram | 0.29 | Bullish |
| vs SMA20 | 1.023x | Above |
| vs SMA50 | 1.049x | Above |
| vs SMA200 | 1.103x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $99.93
- **Stop Loss:** $96.63 (3.3% risk)
- **Target:** $103.23 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 272
- **Position Value:** $27,180.96
- **Portfolio %:** 27.18%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with mixed signals requiring caution. VIX at 14.95 suggests calm markets, but record repo borrowing and narrowing breadth (51.4%) indicate stress beneath the surface. Positive yield curve (+62bps) and stable economic data support risk assets, but year-end dynamics mask true liquidity conditions.*

### Earnings

**Next:** 2026-01-21 (Est: $1.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.25 | $1.31 | +5.2% |
| 2025Q2 | $1.10 | $1.14 | +3.8% |
| 2025Q1 | $1.01 | $1.04 | +3.2% |
| 2024Q4 | $0.91 | $1.01 | +10.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*